Neptune Technologies & Bioressources Inc.
(Toronto Stock Exchange : NEPT)

( )
NEPT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.81%174.661.2%$575.79m
CELGCelgene Corporation
0.60%89.491.2%$535.84m
GILDGilead Sciences, Inc.
0.42%74.010.9%$421.63m
BIIBBiogen Inc.
-1.41%259.301.2%$416.64m
REGNRegeneron Pharmaceuticals, Inc.
0.56%316.012.7%$245.42m
INCYIncyte Corporation
-0.42%68.142.5%$245.05m
VRTXVertex Pharmaceuticals Incorporated
0.34%158.691.9%$226.49m
ALXNAlexion Pharmaceuticals, Inc.
0.05%107.832.0%$209.17m
NKTRNektar Therapeutics
-0.88%85.456.0%$201.71m
ILMNIllumina, Inc.
0.51%245.853.5%$184.02m
AAgilent Technologies, Inc.
0.74%68.051.5%$157.16m
ALNYAlnylam Pharmaceuticals, Inc
-1.66%95.869.8%$140.19m
BLUEBluebird Bio, Inc.
-1.32%168.2515.8%$127.75m
EXASExact Sciences Corporation
2.48%48.7025.7%$111.34m
BMRNBioMarin Pharmaceutical Inc.
-0.27%82.084.4%$104.77m

Company Profile

Neptune Technologies & Bioresources, Inc. engages in the development and commercialization of marine derived omega-3 polyunsaturated fatty acids. It operates through three segments: Neptune, Acasti and NeuroBio. The Neptune segment involves the production and commercialization of nutraceutical products. The Acasti segment involves the development and commercialization of medical food and pharmaceutical products for cardiovascular diseases. The NeuroBio segment involves the development of medical food and pharmaceutical products for neurological diseases. The company was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.